Skip to main content
Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.280
-0.010 (-3.45%)
At close: Mar 10, 2026

BOM:524661 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Net Income
-21.7-1.751.020.240.55
Upgrade
Depreciation & Amortization
-0.080.36---
Upgrade
Other Operating Activities
-6.1-00--
Upgrade
Change in Accounts Receivable
--189.5----
Upgrade
Change in Inventory
--1,435----
Upgrade
Change in Accounts Payable
-28.98----
Upgrade
Change in Other Net Operating Assets
--652.410.110.05-0.05-0.13
Upgrade
Operating Cash Flow
--2,220-1.281.070.190.42
Upgrade
Operating Cash Flow Growth
---476.20%-56.02%-
Upgrade
Capital Expenditures
--0.17----
Upgrade
Investment in Securities
--1.65---
Upgrade
Other Investing Activities
--0.47----
Upgrade
Investing Cash Flow
--0.641.65---
Upgrade
Long-Term Debt Issued
-1,232----
Upgrade
Long-Term Debt Repaid
---0.17-14.92--
Upgrade
Net Debt Issued (Repaid)
-1,232-0.17-14.92--
Upgrade
Issuance of Common Stock
-990-13.21--
Upgrade
Financing Cash Flow
-2,222-0.17-1.72--
Upgrade
Miscellaneous Cash Flow Adjustments
-00---
Upgrade
Net Cash Flow
-1.070.2-0.650.190.42
Upgrade
Free Cash Flow
--2,220-1.281.070.190.42
Upgrade
Free Cash Flow Growth
---476.20%-56.02%-
Upgrade
Free Cash Flow Margin
--904.46%--17.67%31.64%
Upgrade
Free Cash Flow Per Share
--2.59-0.010.010.000.00
Upgrade
Levered Free Cash Flow
--1,3901.010.310.150.47
Upgrade
Unlevered Free Cash Flow
--1,3901.010.310.150.47
Upgrade
Change in Working Capital
--2,2480.110.05-0.05-0.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.